REATA PHARMACEUTICALS INC Operating Expenses
REATA PHARMACEUTICALS INC reported Operating Expenses of $114.95 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2023-08-08
- REATA PHARMACEUTICALS INC operating expenses for the quarter ending 2023-06-30 was $114.95M, a 77.54% increase year-over-year.
- REATA PHARMACEUTICALS INC operating expenses for the quarter ending 2023-03-31 was $110.65M, a 70.35% increase year-over-year.
- REATA PHARMACEUTICALS INC operating expenses for the quarter ending 2022-12-31 was $79.52M, a 9.69% increase year-over-year.
- REATA PHARMACEUTICALS INC operating expenses for the quarter ending 2022-09-30 was $71.03M, a 8.46% increase year-over-year.
- REATA PHARMACEUTICALS INC operating expenses for fiscal 2022 was $280.25M, a 9.39% increase from fiscal 2021.
- REATA PHARMACEUTICALS INC operating expenses for fiscal 2021 was $256.20M, a 8.86% increase from fiscal 2020.
- REATA PHARMACEUTICALS INC operating expenses for fiscal 2020 was $235.34M, a 24.51% decline from fiscal 2019.
- REATA PHARMACEUTICALS INC operating expenses for fiscal 2019 was $311.74M, a 138.94% increase from fiscal 2018.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2023-06-30 | $114.95M 10-Q · filed 2023-08-08 | $225.60M 10-Q · filed 2023-08-08 | $305.12M derived: sum of 3 quarters · filed 2023-08-08 | $376.15M derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | $110.65M 10-Q · filed 2023-05-10 | $190.17M derived: sum of 2 quarters · filed 2023-05-10 | $261.20M derived: sum of 3 quarters · filed 2023-05-10 | $325.95M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-12-31 | $79.52M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $150.55M derived: sum of 2 quarters · filed 2023-02-24 | $215.30M derived: sum of 3 quarters · filed 2023-08-08 | $280.25M 10-K · filed 2023-02-24 |
| 2022-09-30 | $71.03M 10-Q · filed 2022-11-08 | $135.77M derived: sum of 2 quarters · filed 2023-08-08 | $200.73M 10-Q · filed 2022-11-08 | $273.23M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-06-30 | $64.75M 10-Q · filed 2023-08-08 | $129.70M 10-Q · filed 2023-08-08 | $202.20M derived: sum of 3 quarters · filed 2023-08-08 | $267.69M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $64.95M 10-Q · filed 2023-05-10 | $137.45M derived: sum of 2 quarters · filed 2023-05-10 | $202.94M derived: sum of 3 quarters · filed 2023-05-10 | $265.29M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $72.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $137.99M derived: sum of 2 quarters · filed 2023-02-24 | $200.34M derived: sum of 3 quarters · filed 2023-02-24 | $256.20M 10-K · filed 2023-02-24 |
| 2021-09-30 | $65.49M 10-Q · filed 2022-11-08 | $127.84M derived: sum of 2 quarters · filed 2022-11-08 | $183.70M 10-Q · filed 2022-11-08 | $240.87M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $62.35M 10-Q · filed 2022-08-08 | $118.21M 10-Q · filed 2022-08-08 | $175.38M derived: sum of 3 quarters · filed 2022-08-08 | $231.17M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $55.86M 10-Q · filed 2022-05-10 | $113.03M derived: sum of 2 quarters · filed 2022-05-10 | $168.82M derived: sum of 3 quarters · filed 2022-05-10 | $222.48M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $57.17M 10-K · filed 2021-03-01 | $112.96M derived: sum of 2 quarters · filed 2021-11-08 | $166.63M derived: sum of 3 quarters · filed 2021-11-08 | $235.34M 10-K · filed 2023-02-24 |
| 2020-09-30 | $55.79M 10-Q · filed 2021-11-08 | $109.45M derived: sum of 2 quarters · filed 2021-11-08 | $178.17M 10-Q · filed 2021-11-08 | $365.27M derived: sum of 4 quarters · filed 2021-11-08 |
| 2020-06-30 | $53.67M 10-Q · filed 2021-08-09 | $122.39M 10-Q · filed 2021-08-09 | $309.49M derived: sum of 3 quarters · filed 2021-08-09 | $356.31M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | $68.72M 10-Q · filed 2021-05-06 | $255.82M derived: sum of 2 quarters · filed 2021-05-06 | $302.64M derived: sum of 3 quarters · filed 2021-05-06 | $344.13M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $187.10M 10-K · filed 2021-03-01 | $233.92M derived: sum of 2 quarters · filed 2021-03-01 | $275.42M derived: sum of 3 quarters · filed 2021-03-01 | $311.74M 10-K · filed 2022-02-28 |
| 2019-09-30 | $46.82M 10-K · filed 2021-03-01 | $88.31M derived: sum of 2 quarters · filed 2021-03-01 | $124.63M 10-Q · filed 2020-11-09 | $158.01M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $41.49M 10-K · filed 2021-03-01 | $77.81M 10-Q · filed 2020-08-10 | $111.19M derived: sum of 3 quarters · filed 2021-03-01 | $145.92M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $36.32M 10-K · filed 2021-03-01 | $69.69M derived: sum of 2 quarters · filed 2021-03-01 | $104.43M derived: sum of 3 quarters · filed 2021-03-01 | $138.65M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $33.37M 10-K · filed 2020-02-19 | $68.11M derived: sum of 2 quarters · filed 2020-02-19 | $102.33M derived: sum of 3 quarters · filed 2020-02-19 | $130.47M 10-K · filed 2021-03-01 |
| 2018-09-30 | $34.73M 10-K · filed 2020-02-19 | $68.96M derived: sum of 2 quarters · filed 2020-02-19 | $97.09M 10-Q · filed 2019-11-12 | $123.58M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-06-30 | $34.22M 10-K · filed 2020-02-19 | $62.36M 10-Q · filed 2019-08-08 | $88.85M derived: sum of 3 quarters · filed 2020-02-19 | $113.42M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-03-31 | $28.14M 10-K · filed 2020-02-19 | $54.63M derived: sum of 2 quarters · filed 2020-02-19 | $79.20M derived: sum of 3 quarters · filed 2020-02-19 | $103.20M derived: sum of 4 quarters · filed 2020-02-19 |
| 2017-12-31 | $26.49M 10-K · filed 2019-02-28 | $51.06M derived: sum of 2 quarters · filed 2019-02-28 | $75.06M derived: sum of 3 quarters · filed 2019-02-28 | $94.97M 10-K · filed 2020-02-19 |
| 2017-09-30 | $24.57M 10-K · filed 2019-02-28 | $48.58M derived: sum of 2 quarters · filed 2019-02-28 | $68.48M 10-Q · filed 2018-11-07 | $85.22M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $24.00M 10-K · filed 2019-02-28 | $43.91M 10-Q · filed 2018-08-08 | $60.64M derived: sum of 3 quarters · filed 2019-02-28 | $74.15M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $19.91M 10-K · filed 2019-02-28 | $36.64M derived: sum of 2 quarters · filed 2019-02-28 | $50.15M derived: sum of 3 quarters · filed 2019-02-28 | $63.94M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $16.74M 10-K · filed 2018-03-02 | $30.25M derived: sum of 2 quarters · filed 2018-03-02 | $44.04M derived: sum of 3 quarters · filed 2018-03-02 | $56.74M 10-K · filed 2019-02-28 |
| 2016-09-30 | $13.51M 10-K · filed 2018-03-02 | $27.30M derived: sum of 2 quarters · filed 2018-03-02 | $40.00M 10-Q · filed 2017-11-13 | $53.09M derived: sum of 4 quarters · filed 2018-03-02 |
| 2016-06-30 | $13.79M 10-K · filed 2018-03-02 | $26.49M 10-Q · filed 2017-08-14 | $39.58M derived: sum of 3 quarters · filed 2018-03-02 | $51.59M derived: sum of 4 quarters · filed 2018-03-02 |
| 2016-03-31 | $12.70M 10-K · filed 2018-03-02 | $25.79M derived: sum of 2 quarters · filed 2018-03-02 | $37.80M derived: sum of 3 quarters · filed 2018-03-02 | $51.39M derived: sum of 4 quarters · filed 2018-03-02 |
| 2015-12-31 | $13.09M 10-K · filed 2017-03-03 | $25.10M derived: sum of 2 quarters · filed 2017-03-03 | $38.69M derived: sum of 3 quarters · filed 2017-03-03 | $50.65M 10-K · filed 2018-03-02 |
| 2015-09-30 | $12.02M 10-K · filed 2017-03-03 | $25.60M derived: sum of 2 quarters · filed 2017-03-03 | $37.57M 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $13.59M 10-K · filed 2017-03-03 | $25.55M 10-Q · filed 2016-08-11 | ||
| 2015-03-31 | $11.96M 10-K · filed 2017-03-03 | |||
| 2014-12-31 | $48.33M 10-K · filed 2017-03-03 |